Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents

Area of Science:

• Oncology
• Nanomedicine
• Pharmacology

Background:

• Cancer remains a leading global cause of mortality, with existing treatments having limitations.
• Nanotechnology offers novel approaches to cancer therapy, focusing on enhanced specificity and reduced drug concentrations.
• Nanomedicine utilizes nanoparticles for targeted delivery to cancer cells, aiming for improved therapeutic outcomes.

Purpose of the Study:

• To review the anticancer activities of medicinal plants and their active compounds.
• To discuss green-synthesized metallic nanoparticles derived from medicinal plants.
• To highlight the potential of nanodrugs in cancer treatment.

Main Methods:

• Literature review of medicinal plants with anticancer properties.
• Analysis of active compounds isolated from these plants.
• Examination of green synthesis methods for metallic nanoparticles using plant extracts.
• Evaluation of the anticancer efficacy of these nanoparticles.

Main Results:

• Medicinal plants and their compounds exhibit significant anticancer potential.
• Green synthesis provides an effective route to produce metallic nanoparticles with anticancer activity.
• Nanoparticles demonstrate higher efficacy and fewer side effects compared to conventional cancer drugs.

Conclusions:

• Medicinal plants are a valuable source for developing novel anticancer agents.
• Green-synthesized metallic nanoparticles represent a promising frontier in nanomedicine for cancer therapy.
• Further research into nanodrugs derived from natural sources could revolutionize cancer treatment.